Remdesivir and GS-441524

被引：0
|
作者：
Yan, Victoria
机构：
来源：
CHEMICAL & ENGINEERING NEWS | 2021年 / 99卷 / 23期
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [31] Outcomes of treatment of cats with feline infectious peritonitis using parenterally administered remdesivir, with or without transition to orally administered GS-441524
    Coggins, Sally J.
    Norris, Jacqui M.
    Malik, Richard
    Govendir, Merran
    Hall, Evelyn J.
    Kimble, Benjamin
    Thompson, Mary F.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2023, 37 (05) : 1772 - 1783
  • [32] Remdesivir and GS-441524 Retain Antiviral Activity against Delta, Omicron, and Other Emergent SARS-CoV-2 Variants
    Pitts, Jared
    Li, Jiani
    Perry, Jason K.
    Du Pont, Venice
    Riola, Nicholas
    Rodriguez, Lauren
    Lu, Xianghan
    Kurhade, Chaitanya
    Xie, Xuping
    Camus, Gregory
    Manhas, Savrina
    Martin, Ross
    Shi, Pei-Yong
    Cihlar, Tomas
    Porter, Danielle P.
    Mo, Hongmei
    Maiorova, Evguenia
    Bilello, John P.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (06)
  • [33] GS-441524 inhibits African swine fever virus infection in vitro
    Huang, Zhao
    Gong, Lang
    Zheng, Zezhong
    Gao, Qi
    Chen, Xiongnan
    Chen, Yang
    Chen, Xiaojun
    Xu, Runda
    Zheng, Jiachen
    Xu, Zhiying
    Zhang, Shengxun
    Wang, Heng
    Zhang, Guihong
    ANTIVIRAL RESEARCH, 2021, 191
  • [34] Development and validation of a paper spray mass spectrometry method for the rapid quantitation of remdesivir and its active metabolite, GS-441524, in human plasma
    Skaggs, Christine
    Zimmerman, Hannah
    Manicke, Nicholas
    Kirkpatrick, Lindsey
    JOURNAL OF MASS SPECTROMETRY AND ADVANCES IN THE CLINICAL LAB, 2022, 25 : 27 - 35
  • [35] GS-441524 Parent Nucleoside to Remdesivir Can Effectively Inhibits Sars-Cov-2 Omicron Infections in Human Lung Organoids
    Liang, J.
    Li, Y.
    Khateeb, J.
    Khang, J.
    Slutsky, A.
    Mubareka, S.
    Zhang, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [36] THE EFFECT OF CLOFAZIMINE IN MODULATING INTRACELLULAR CONCENTRATIONS OF REMDESIVIR AND GS-441524: A POTENTIAL MECHANISM OF ENHANCING ANTIVIRAL EFFECTS AGAINST SARS-COV-2
    Jony, Md Rasheduzzaman
    Shin, Jae Gook
    Cho, Yong Soon
    Howlader, Saurav
    Kim, Dong Hyun
    DRUG METABOLISM AND PHARMACOKINETICS, 2024, 55
  • [37] Potency and pharmacokinetics of GS-441524 derivatives against SARS-CoV-2
    Wei, Daibao
    Hu, Tianwen
    Zhang, Yumin
    Zheng, Wei
    Xue, Haitao
    Shen, Jingshan
    Xie, Yuanchao
    Aisa, Haji A.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 46
  • [38] Population pharmacokinetics and exposure-clinical outcome relationship of remdesivir major metabolite GS-441524 in patients with moderate and severe COVID-19
    Tamura, Ryo
    Irie, Kei
    Nakagawa, Atsushi
    Muroi, Hirohito
    Eto, Masaaki
    Ikesue, Hiroaki
    Muroi, Nobuyuki
    Fukushima, Shoji
    Tomii, Keisuke
    Hashida, Tohru
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2023, 12 (04): : 513 - 521
  • [39] Exploration for the effect of renal function and renal replacement therapy on pharmacokinetics of remdesivir and GS-441524 in patients with COVID-19: A limited case series
    Choe, Pyoeng Gyun
    Jeong, Sae Im
    Kang, Chang Kyung
    Yang, Liju
    Lee, SeungHwan
    Cho, Joo-Youn
    Han, Seung Seok
    Kim, Dong Ki
    Lee, Sang Min
    Park, Wan Beom
    Oh, Myoung-Don
    Kim, Nam Joong
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 15 (03): : 732 - 740
  • [40] Exploration of the optimal GS-441524 trough concentration for treating COVID-19
    Nakano, Yuki
    Inokuchi, Yoko
    Hayama, Tadashi
    Hirai, Toshinori
    Nishiyama, Mamoru
    Sueyasu, Yoshiko
    Yokoo, Kenjo
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2023, 62 (02)
12345